Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Molina

Showing results (521-530 of 647) with videos related to

Pageof 65
Sort By:
Cancer|January 11, 2011
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326Grace K Dy, Shauna L Hillman, Kendrith M Rowland, et al.
Archivos Espanoles De Urologia|January 10, 2012
Bladder augmentation using the gastrointestinal tract. Indication, follow up and complicationsR Molina Escudero, G Escribano Patiño, E Rodríguez Fernández, et al.
Medicina Intensiva|June 15, 2010
[Ethics of the cardiopulmonary resuscitation decisions]J L Monzón, I Saralegui, R Molina, et al.
The Journal of Clinical Investigation|April 22, 2010
FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growthJun Zhang, Deping Zhao, Hwan Ki Park, et al.
Water Research|July 19, 2013
Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutantsF Martínez, M J López-Muñoz, J Aguado, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 25, 2025
Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social supportRyan Brown, Katie E Smith, Mohamed M Shanshal, et al.
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Archivos Espanoles De Urologia|September 1, 2009
[Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases]Juan Ignacio Monzó Gardiner, F Herranz Amo, R Cabello Benavente, et al.
Psycho-Oncology|December 1, 2007
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief reportFarrah J Mateen, Aminah Jatoi, Timothy W Lineberry, et al.
Disease Markers|September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniquesR Molina, S Oesterreich, J L Zhou, et al.
Pageof 65

Showing results (521-530 of 647) with videos related to

Sort By:
Pageof 65
Cancer|January 11, 2011
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326Grace K Dy, Shauna L Hillman, Kendrith M Rowland, et al.
Archivos Espanoles De Urologia|January 10, 2012
Bladder augmentation using the gastrointestinal tract. Indication, follow up and complicationsR Molina Escudero, G Escribano Patiño, E Rodríguez Fernández, et al.
Medicina Intensiva|June 15, 2010
[Ethics of the cardiopulmonary resuscitation decisions]J L Monzón, I Saralegui, R Molina, et al.
The Journal of Clinical Investigation|April 22, 2010
FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growthJun Zhang, Deping Zhao, Hwan Ki Park, et al.
Water Research|July 19, 2013
Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutantsF Martínez, M J López-Muñoz, J Aguado, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 25, 2025
Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social supportRyan Brown, Katie E Smith, Mohamed M Shanshal, et al.
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Archivos Espanoles De Urologia|September 1, 2009
[Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases]Juan Ignacio Monzó Gardiner, F Herranz Amo, R Cabello Benavente, et al.
Psycho-Oncology|December 1, 2007
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief reportFarrah J Mateen, Aminah Jatoi, Timothy W Lineberry, et al.
Disease Markers|September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniquesR Molina, S Oesterreich, J L Zhou, et al.
Pageof 65